期刊文献+

直接心肌内注射碱性成纤维细胞生长因子基因改善慢性缺血心肌收缩功能的实验研究

Experimental study on effects of direct intramyocardial injection of basic fibroblast growth factor gene on systolic function of chronic ischemic myocardiam
下载PDF
导出
摘要 目的观察直接心肌内注射碱性成纤维细胞生长因子(bFGF)基因对慢性缺血心肌收缩功能的改善作用。方法将10只猪的慢性心肌缺血模型,随机分为bFGF基因治疗组(A组,6只)和对照组(B组,4只)。超声心动图(UCG)和MRI检测左心室射血分数(LVEF)和室壁增厚率(WT),评价左心室收缩功能。治疗后6周,目标区心肌标本进行心肌微血管计数。结果bFGF基因治疗后6周,UCG测得A组LVEF和WT均较治疗前提高(P<0.05),WT提高到正常值水平;A组WT值高于B组(P<0.05)。MRI测得A组LVEF和WT均较治疗前提高(P<0.05),并且达到正常值水平;A组LVEF和WT均高于B组(P<0.05)。A组心肌微血管计数多于B组(P=0.031)。结论直接心肌内注射bFGF基因可以促进心肌细小血管新生,改善慢性缺血心肌局部和左心室整体的收缩功能。 Objective To evaluate the effect of intramyocardial injection of the basic fibroblast growth factor (bFGF) gene on left ventricular systolic function in porcine model of chronic myocardial ischemia. Methods Ten chronic myocardial ischemic porcine models were divided into two groups, group A( bFGF gene treatment group, n =6) and group B (control group, n =4). UCG and MRI were used and left ventricular ejection fraction (LVEF) and systolic wall thickening (WT) were examined to assess the left ventricular systolic func- tion. Six weeks after the treatment, the target myocardial tissue sections were stained with hematoxylin/eosin (HE) and the capillary density was calculated. Results UCG results showed that six weeks after bFGF gene therapy, LVEF and WT in group A were significantly improved as compared with those before treatment ( P 〈 0.05), WT was increased to the normal level and was significantly higher than that in group B ( P = 0.004). MRI results indicated that in group A, both LVEF and WT were increased to normal levels six weeks after bFGF gene treatment and were significantly higher than those before treatment ( P 〈 0.05). While in group B, neither LVEF nor WT was significantly changed as compared with those before treatment and both were significantly lower than the normal levels ( P = 0. 000). At the study endpoint, LVEF and WT in group A were significantly higher than those in group B ( P =0.000). The capillary density in group A was significantly higher than that in group B ( P = 0. 031). Conclusions Direct intramyocardial injection of bFGF gene can significantly enhance angiogensis and collateral circulation, which contribute to the significant improvement of regional or global left ventricular systolic function in chronic myocardial ischemia of porcine heart.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2006年第5期339-342,共4页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 成纤维细胞因子2 心肌缺血 基因疗法 心肌功能 fibroblast growth factor 2 myocardial ischemia gene therapy:myocardial function
  • 相关文献

参考文献13

  • 1Banai S, Jaklitsch MY, Casscells W, et al. Effects of acidic fibroblast growth factor on normal and ischemic myocardium[J]. Circ Res, 1991,69: 76-85.
  • 2Keith A, John D, Chia-Yang J, et al. Myocardial functional recovery after fibroblast growth factor 2 gene therapy as assessed by echocardiography and magnetic resonance imaging[J]. Ann Thorac Surg,2002,74:481-487.
  • 3Udelson JE, Dilsizian V, l.aham RJ, et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease [J]. Circulation, 2000, 102: 1605-1610.
  • 4屈正,商建峰,安春雷,汪道文,张兆光,党海明,卿恩明,张慧信,许斌.激光联合血管内皮生长因子基因促进缺血心肌血管再生的实验研究[J].中国激光医学杂志,2002,11(4):213-217. 被引量:2
  • 5屈正,安春雷,党海明,李书闻,商建峰,王学勇,许斌.中国实验小型猪慢性心肌缺血模型的制备与研究[J].中华实验外科杂志,2001,18(3):281-281. 被引量:15
  • 6Dzau MJ, Ehsan A, Griese DP, et al. Gene therapy and genomic strategies for cardiovascular surgery: the emerging field of surgiomics[J]. J Thorac Cardiovasc Surg, 2001,121:206-216.
  • 7Lee Y, Patel SR, Hackett NR, et al. Focal angiogen therapy using intramyocarlial delivery of an adenovims vector coding for vascular endothelial growth factor 121[J]. Ann Thorac Surg,2000,69:14-24.
  • 8Christian TF. Detecting the effects of angiogenic therapy: how do we measure efficacy[J]? Curr Interv Cardiol Rep, 1999,1:310-321.
  • 9Wall EE, Rugge FP, Vliegen HW, et al. Ischemic heart disease:value of MR techniques[J]. Int J Card Imaging, 1997,13:179-189.
  • 10Taylor AM, PenneU DJ. Recent advances in cardiac magnetic resonance imaging[J]. Curr Opin Cardiol, 1996,11:635-642.

二级参考文献13

  • 1Symes JF, Losordo DW, Vale PR, et al. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease[J]. Ann Thorac Surg, 1999, 68:830~837.
  • 2Rosengart TK, Lee LY, Patel SR, et al. Angiogenesis gene therapy: phase Ⅰ assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease[J]. Circulation, 1999, 100:468~474.
  • 3Sayeed-Shah U, Mann MJ, Martin J, et al. Complete reversal of ischemic wall motion abnormalities by combined use of gene therapy with transmyocardial laser revascularization[J]. J Thorac Cardiovasc Surg, 1998, 116:763~769.
  • 4Horvath KA, Chiu E, Maun DC, et al. Up-regulation of vascular endothelial growth factor mRNA and angiogenesis after transmyocardial laser revascularization[J]. Ann Thorac Surg, 1999, 68:825~829.
  • 5Brilla CG, Rybinski L, Gehrke D, et al. Transmyocardial laser revascularization-an innovative pathophysiologic concept[J]. Herz, 1997, 22:183~189.
  • 6Fleischer KJ, Goldschmidt-Clermont PJ, Fonger JD, et al. One month histologic response of transmyocardial laser channels with molecular intervention[J]. Ann Thorac Surg, 1996, 62:1051~1058.
  • 7Sayeed-Shah U, Reul RM, Byrne JG, et al. Combination TMR and gene therapy[J]. Semin Thorac Cardiovasc Surg, 1999, 11:36~39.
  • 8Malekan R,Reynolds CA,Kelley ST,et al.Angiogenesis in transmyocardial laser revascularization: a nonspecific response to injury[].Circulation.1997
  • 9O’konski M S,White F C,Long hurst J C,et al.Ameroid constriction of the proximal left circumflex coronary artery in swine[].American Journal of Cardiovascular Drugs.1987
  • 10屈正,张兆光.血管内皮生长因子基因心肌血运重建治疗冠心病[J].中华胸心血管外科杂志,2000,16(5):309-311. 被引量:2

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部